GlassScriptPhysician profile
Thomas J Elardo
NPI 1023112554
$10,188.07
in general payments reported to CMS, 2019-2025
38 companies · $1,600 in 2025
The $1,600 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,884 · 2020: $906 · 2021: $412 · 2022: $1,129 · 2023: $2,201 · 2024: $2,055 · 2025: $1,600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,012 · Travel and Lodging: $844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,012.05 |
| Travel and Lodging | $844.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,711.24 | 2019-2025 | Collagenase Santyl, Grafix, Stravix |
| Arthrex, INC. | $1,202.10 | 2023 | |
| Stryker Corporation | $681.16 | 2022-2025 | Augment Injectable, Ortholoc 2 Lapifuse, N/A |
| Paratek Pharmaceuticals, INC. | $498.94 | 2021-2025 | Nuzyra |
| Integra Lifesciences Corporation | $473.53 | 2019-2020 | |
| Nevro Corp. | $421.31 | 2022-2023 | Senza |
| Treace Medical Concepts, INC. | $415.95 | 2021-2025 | |
| Depuy Synthes Sales INC. | $410.83 | 2019-2025 | Motoband, Hammerlock, Motoband Cp |
| Alafair Biosciences, INC. | $354.13 | 2024-2025 | Versawrap |
| Medical Device Business Services, INC. | $338.86 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $309.54 | 2020-2023 | |
| Zimmer Biomet Holdings, INC. | $290.56 | 2020-2022 | |
| Biotissue Holdings INC. | $264.82 | 2022-2024 | |
| Amgen INC. | $253.21 | 2024-2025 | Krystexxa |
| Exactech, INC. | $212.75 | 2024 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $208.54 | 2019-2023 | Mtp, Paratrooper |
| Organogenesis INC. | $195.86 | 2020-2023 | Puraply |
| Kerecis Limited | $195.73 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Averitas Pharma INC. | $194.59 | 2024 | Qutenza |
| Abbott Laboratories | $189.76 | 2025 | Esprit |
| Avita Medical Americas, LLC | $154.70 | 2024-2025 | Recell |
| Wright Medical Technology, INC. | $149.13 | 2019-2020 | |
| Horizon Therapeutics Plc | $140.04 | 2019-2023 | Krystexxa |
| Evolution Surgical, INC | $122.22 | 2019-2023 | |
| Linvatec Corporation | $111.50 | 2023 | Colink Plating System, Fracture and Correction Colag 2 |
| Curonix LLC | $110.70 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Medline Industries LP | $104.67 | 2019 | |
| Osiris Therapeutics INC. | $77.25 | 2019 | |
| Bioventus LLC | $58.96 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Vertex Pharmaceuticals Incorporated | $58.15 | 2024-2025 | |
| Ani Pharmaceuticals, INC. | $55.38 | 2025 | Purified Cortrophin Gel |
| Fidia Pharma USA INC. | $46.80 | 2019-2020 | |
| Zyla Life Sciences, INC. | $44.18 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $43.75 | 2020 | |
| Melinta Therapeutics, LLC | $34.04 | 2019 | |
| Amniox Medical, INC. | $24.53 | 2020 | |
| Bone Support INC. | $16.01 | 2025 | Cerament G, Ceramentbone Void Filler |
| Arthrosurface Incorporated | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Elardo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.